Clinical trials
Phase 2 Metabolic Diseases trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2014 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Akcea Therapeutics | 3 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Anelixis Therapeutics, LLC | 1 |
| Eli Lilly and Company | 1 |
| Pfizer | 1 |
| Rezolute | 1 |
| The Hospital for Sick Children | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Metabolic Diseases | 9 |
| Lipid Metabolism Disorders | 5 |
| Dyslipidemias | 4 |
| Genetic Diseases, Inborn | 3 |
| Hyperlipidemias | 3 |
| Hyperlipoproteinemias | 3 |
| Digestive System Diseases | 2 |
| Endocrine System Diseases | 2 |
| Glucose Metabolism Disorders | 2 |
| Hypertriglyceridemia | 2 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.